Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Administration : Once-weekly injection
It is commonly administered through subcutaneous injection under medical guidance to ensure proper dosing and response monitoring
Comprehensive meta-analyses of randomized controlled trials indicated no significant association between DPP-4 inhibitor therapy and overall cancer risk
Method Development Tips Method development often begins with small pilot plates before larger screening panels
Background The scientific foundation for GLP-1 receptor agonists dates back to the early twentieth century, when researchers first hypothesized that the duodenal mucosa secretes a hormone acting on the pancreas to stimulate insulin release after meals, an effect later named the incretin effect by Jean La Barre in 1932
US$ 27.12
US$ 27.05
US$ 29.12
US$ 20.21
US$ 27.33
US$ 24.73
